<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00957788</url>
  </required_header>
  <id_info>
    <org_study_id>NST-CP-02</org_study_id>
    <nct_id>NCT00957788</nct_id>
  </id_info>
  <brief_title>Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus</brief_title>
  <official_title>Safety and Feasibility Study of NST - 001 in Inner Ear Using Neuroject Injection Set for the Treatment of Tinnitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NeuroSystec Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NeuroSystec Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study involves an experimental drug (NST_001) and a delivery system. The main
      purpose of this research study is to investigate the safety of NST-001, delivered directly to
      the inner ear for the treatment of tinnitus.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">May 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjects will be followed for identification and frequency of drug or procedure-related adverse events.</measure>
    <time_frame>At each follow-up visit.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Observe any effect on tinnitus as determined by the visual analog scale, subject tinnitus diary, and investigator interview.</measure>
    <time_frame>At each follow-up visit.</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>Cohort 0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NST-001</intervention_name>
    <description>Comparison of different dosages of drug.</description>
    <arm_group_label>Cohort 0</arm_group_label>
    <arm_group_label>Cohort 1</arm_group_label>
    <arm_group_label>Cohort 2</arm_group_label>
    <arm_group_label>Cohort 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients able to provide voluntary consent.

          -  Severe tinnitus in one ear that began no more than ten years ago.

          -  Ear to be treated must be deaf or have profound hearing loss.

          -  Subjects with cardiac disease or hypertension, must have stable disease for at least 6
             months.

          -  Subject must have intact cochlear nerve on the ear to be treated.

          -  Women of childbearing potential (i.e., not post-menopausal or surgically sterilized)
             must agree to use adequate birth control methods as recommended by the study
             physician.

        Exclusion Criteria:

          -  Current diagnosis of bilateral tinnitus.

          -  Current diagnosis or history of pancreatitis.

          -  Females that are pregnant or lactating.

          -  Use of investigational drugs within the previous 30 days.

          -  History of drug dependency or other substance abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Frachet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Avicenne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Garin, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cliniques Universitaries U.C.L.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques Universitaries U.C.L.</name>
      <address>
        <city>Mont-Godinne</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <state>Cedex</state>
        <zip>93009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2009</study_first_submitted>
  <study_first_submitted_qc>August 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2009</study_first_posted>
  <last_update_submitted>April 18, 2013</last_update_submitted>
  <last_update_submitted_qc>April 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tinnitus</keyword>
  <keyword>acouphenes</keyword>
  <keyword>ear</keyword>
  <keyword>ringing</keyword>
  <keyword>buzzing</keyword>
  <keyword>roaring</keyword>
  <keyword>hissing</keyword>
  <keyword>clicking</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

